1. Home
  2. FC vs RNAC Comparison

FC vs RNAC Comparison

Compare FC & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Covey Company

FC

Franklin Covey Company

HOLD

Current Price

$16.83

Market Cap

193.2M

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$6.74

Market Cap

175.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FC
RNAC
Founded
1983
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
175.8M
IPO Year
1992
2016

Fundamental Metrics

Financial Performance
Metric
FC
RNAC
Price
$16.83
$6.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$24.50
$38.40
AVG Volume (30 Days)
124.2K
255.0K
Earning Date
01-07-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$267,067,000.00
$1,091,000.00
Revenue This Year
$2.82
N/A
Revenue Next Year
$4.35
N/A
P/E Ratio
$70.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.04
$5.98
52 Week High
$39.22
$20.12

Technical Indicators

Market Signals
Indicator
FC
RNAC
Relative Strength Index (RSI) 53.77 43.62
Support Level $16.63 $6.40
Resistance Level $17.48 $6.88
Average True Range (ATR) 0.47 0.60
MACD 0.02 -0.04
Stochastic Oscillator 51.70 12.72

Price Performance

Historical Comparison
FC
RNAC

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Share on Social Networks: